Federal Register / Vol. 63, No. 76 /Tuesday, April 21, 1998 / Notices 19737

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: April 14, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–10441 Filed 4–20–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health (NIH)

National Institute on Aging; Notice of

Meeting of the National Advisory

Council on Aging

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the National Advisory Council on

Aging, National Institute on Aging,

Thursday, May 21, and Friday, May 22,

1998, to be held at the National

Institutes of Health, Building 31,

Conference Room 6, Bethesda,

Maryland. This meeting will be open to

the public on Thursday, May 21, from

2:30 to 4:15 p.m. for a status report by

the Director, NIA, and a Panel

Discussion.

The meeting will be open again on

Friday, May 22, from 8 a.m. to

adjournment for a report on the Working

Group on Program, a report on the

Minority Aging Task Force, a

presentation on Minority Health, a

report on the Task Force on Training

and Program Highlights. Attendance by

the public will be limited to space

available.

In accordance with the provisions set

forth in sections 552b(c)(4) and

552b(c)(6), Title 5, U.S.C. and section

10(d) of Public Law 92–463, the meeting

of the Council will be closed to the

public on Thursday, May 21, from 4:15

p.m. to recess for the discussion and

evaluation of grant applications. These

applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with

the applications, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

Ms. June McCann, Committee

Management Officer for the National

Institute on Aging, National Institutes of

Health, Gateway Building, 7201

Wisconsin Avenue, Suite 2C218,

Bethesda, Maryland 20892 (301/496–

9322), will provide a summary of the

meeting and a roster of committee

members upon request.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. McCann at (301) 496–9322,

in advance of the meeting.

(Catalog of Federal Domestic Assistance

Program No. 93.866, Aging Research,

National Institutes of Health)

Dated: April 14, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–10436 Filed 4–20–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Meeting

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the National Advisory Council on Drug

Abuse, National Institute on Drug Abuse

(NIDA) on May 19–20, 1998, at the

National Institutes of Health, Natcher

Building 45, 9000 Rockville Pike,

Bethesda, MD 20892.

On May 19, from 9 a.m. to 4 p.m., the

meeting will be held in Conference

Rooms E1, E2, G1 and G2. In accordance

with provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

and section 10(d) of Public Law 92–463,

this portion of the meeting will be

closed to the public for the review,

discussion, and evaluation of grant

applications. These applications and the

discussions could reveal confidential

trade secrets or commercial property

such as patentable material and

personal information concerning

individuals associated with the

applications, disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

On May 20, from 9 a.m. to 5 p.m., the

meeting will be held in Conference

Rooms E1 and E2. This portion of the

meeting will be open to the public for

annoncements and reports

administrative, legislative, and program

developments in the drug abuse field.

Attendance by the public will be limited

to space available.

A summary of the meeting and a

roster of committee members may be

obtained from Ms. Camilla L. Holland,

NIDA Committee Management Officer,

National Institutes of Health, Parklawn

Building, Room 10–42, 5600 Fishers

Lane, Rockville, Maryland 20857, (301/

443–2755).

Substantive program information may

be obtained from Dr. Teresa Levitin,

Room 10–42, Parklawn Building, 5600

Fishers Lane, Rockville, Maryland

20857, (301/443–2755).

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Dr. Levitin in advance of the

meeting.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.277, Drug Abuse

Research Scientist Development and

Research Scientist Awards; 93.278, Drug

Abuse National Research Service Awards for

Research Training; 93.279, Drug Abuse

Research Programs)

Dated: April 14, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–10437 Filed 4–20–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Child Health and

Human Development Special Emphasis

Panel (SEP) meeting:

Name of SEP: In Vivo and In Vitro

Evaluation of Terbinafine as a CYP2D6

Inhibitor (TELECONFERENCE).

Date: April 23, 1998.

Time: 10:30 p.m.—adjournment.

Place: 6100 Executive Boulevard, 6100

Building, Room 5E01, Rockville, Maryland

20852.

Contact Person: Gopal Bhatnagar, Ph.D.,

Scientific Review Administrator, NICHD,

6100 Executive Boulevard, Room 5E01,

Rockville, MD 20852, Telephone: 301–496–

1485.

Purpose/Agenda: To evaluate and review

research grant applications.

This meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The

discussion of these applications could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with these applications, the

disclosure of which would constitute a

clearly unwarranted invasion of personal

privacy.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

(Catalog of Federal Domestic Assistance

Program Nos. [93.864, Population Research

and No. 93.865, Research for Mothers and

Children], National Institute of Health, HHS)